A strict 30-day deadline for rare disease drug approvals

Prescription drug coverage for rare diseases.

Enrolled· 2026-08-30

Who's it for

Who's it for: Everyday People

What it means for you

8/10Helps you

Good for everyday people ·

Plain‑English summary, cross‑checked against the official bill text.

This bill forces health insurance companies to approve or deny medicines for rare diseases within 30 days, or else the drug gets approved automatically.

Our take

What we think, in plain words.

Insurance companies often drag their feet when asked to pay for expensive medicines. For patients with rare diseases, waiting for approval can be terrifying. This bill puts a hard 30-day ticking clock on insurers. If they do not make a choice or if they keep arguing past the deadline, they have to pay for the drug. While lawmakers did remove a rule that would have stopped insurers from making patients try cheaper drugs first, this is still a huge win for sick patients who need their medicine right away.

Take action

Add your name. At 100 signatures we compile this petition and deliver it to the office — and every signer gets a message to send their own representatives.

0 of 100 in‑district signatures

Step 1 · Pick your position

Step 2 · Add your name

Picking a side above doesn't sign anything yet — a free account records your name on the petition and keeps it one signature per person. We'll bring you straight back here with your choice saved.

The facts

What the bill actually says, no spin.

Applies to medicines for rare diseases that affect fewer than 200,000 people.
Gives insurance companies exactly 30 days to review a specialist's prescription.
If the insurance company takes too long or keeps arguing past 30 days, the medicine is automatically approved.
Does not apply to people who get their insurance through Medi-Cal.
Lawmakers removed a rule from the original bill that would have stopped insurers from making patients try cheaper drugs first.